Overview · Filed: —
UPC_APP_907/2025
NOVEL ANTITUMORAL USE OF CABAZITAXEL
Procedural & sub-applicationsOther ProceduralMunich LDApplication Rop305—
Parties
Claimants
- Sanofi Mature IP(Sanofi Group)
- Sanofi Winthrop Industrie(Sanofi Group)
- Sanofi-Aventis GmbH(Sanofi Group)
- Sanofi Belgium(Sanofi Group)
- Sanofi-Aventis Deutschland GmbH(Sanofi Group)
- Sanofi S.r.l.(Sanofi Group)
- Sanofi B.V.(Sanofi Group)
- Sanofi - Produtos Farmaceuticos Lda(Sanofi Group)
- Sanofi AB(Sanofi Group)
- Sanofi A/S(Sanofi Group)
Reps: Frédéric Chevallier (Herbert Smith Freehills)
Respondents
- Accord Healthcare S.L.U.
- Accord Healthcare GmbH (AT)
- Accord Healthcare B.V.
- Accord Healthcare GmbH (DE)
- Accord Healthcare Italia Srl
- Accord Healthcare, Unipessoal Lda.
- Accord Healthcare AB
- STADAPHARM GmbH
- STADA Arzneimittel AG
- STADA Nordic ApS
- Reddy Pharma SAS
- betapharm Arzneimittel GmbH
- Dr Reddy's Srl
- Zentiva France
- Zentiva Pharma GmbH
- Zentiva, k.s.
Reps: Jules Fabre (Pinsent Mason); Arjan Reijns (Pinsent Mason); Louise Millot (Pinsent Mason); Daniel Hoppe (Bonabry); Christian Meyer (Maiwald); Andreas Ledl (Maiwald); Anja Lunze (Taylor Wessing); Elisabeth Greiner (df-mp)
Judges
- Matthias ZigannPresiding Judge / Judge-Rapporteur (Munich Local Division)
Patents
- EP 2 493 466
CPC codes: A61K38/193, A61K31/573, A61P35/04, A61K31/164, A61K31/56, A61P43/00, A61P13/08, A61P15/00, A61K31/337, A61P35/00, A61K45/06, A61P25/16
Sector: Pharmaceutical & Medical
Outcome
Procedural only
Filed: —
First decided: Jan 17, 2025
Language: —